4//SEC Filing
CLAFLIN THOMAS M II 4
Accession 0001181431-04-027531
CIK 0000919745other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:57 PM ET
Size
6.3 KB
Accession
0001181431-04-027531
Insider Transaction Report
Form 4
CLAFLIN THOMAS M II
Director
Transactions
- Award
Non-qualified stock option
2004-05-24$6.02/sh+10,000$60,200→ 35,000 totalExercise: $6.02From: 2004-05-24Exp: 2014-05-24→ Common Stock (10,000 underlying)
Holdings
- 883,335(indirect: Held by Black Diamond Fund, L.P.)
Common Stock
Documents
Issuer
POINT THERAPEUTICS INC
CIK 0000919745
Entity typeother
Related Parties
1- filerCIK 0001187889
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 4:57 PM ET
- Size
- 6.3 KB